Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected

Detalles Bibliográficos
Autores principales: Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Coman-Vlagea, Nicoleta, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Infection Association. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847092/
https://www.ncbi.nlm.nih.gov/pubmed/35181372
http://dx.doi.org/10.1016/j.jinf.2022.02.009
Descripción
Sumario:

Ejemplares similares